INVESTING IN THE AGE OF LONGEVITY
2019 – 2021

We are on the verge of a lifespan revolution. In the next 30 years, life expectancy is going to rise to between 110 and 120.

The nascent but rapidly growing longevity industry has the capacity to change forever how we live, and how (and when) we die. Crucially, it will also influence how we successfully invest for the future.

At Master Investor’s Investing in the Age of Longevity events, some of the leading minds in this emerging sector mingled with the world’s most important institutional and private investors to discuss the birth of a new industry – arguably the greatest investment opportunity of all time.

2021 Presentations

2021 Highlights

Watch a 2-minute highlights video of the 2021 event.

Richard Faragher

The Geroscience Promise: The Biology of Age-Related Disease and The Potential of Therapeutic Interventions

Janet Lord

The aged immune system – a central driver of ageing

(NB: for reasons of copyright, confidentiality and compliance, some aspects of this deck have been edited to differ from that delivered live at the event.)

James Kirkland

Senolytics

Michael Hufford

Prometheus Unbound: From Myth to the Clinical Rea- lity of Organ Regeneration

James Peyer

Cambrian Bio – Creating longevity drugs at scale

Greg Bailey

Juvenescence: Re-imagine a Lifetime

Phil Newman, Greg Bailey and James Peyer

Q&A Panel

Dr Geoff Mullan

We love longevity, but my heart’s in healthspan

Daniel Ives

A path to safe cellular rejuvenation

George Sutherland

Crossing the chasm: priming the market for longevity interventions

Larisa Andreeva

A Healthy Brain for Life

Richard Faragher

AFAR Think Tanks Report Findings

Nir Barzilai

Targeting Aging with Metformin (TAME): A Concrete Plan to Pave the Way for Targeting Aging

Jim Mellon, James Peyer, Mehmood Khan and Kristen Fortney

Rejuvenating and uniting the industry to target health span and life span

2020 Webinars

The Opportunity for Investors

The progress being made in extending life- and health-spans represents both a challenge and an opportunity. How can we ensure our investments see us comfortably through an extended life and how can we capitalise on the huge financial possibilities that successful treatments for aging would present? This panel brings together three of the leading investors in the field of Longevity to discuss the opportunities and potential pitfalls.

The Science of Ageing

We are on the cusp of a revolution in our understanding of the causes and consequences of aging. As aging research gathers pace, this panel discussion brings together some of the leading experts in the field of gerontology to discuss the cutting edge scientific work being done to advance the fight against aging.

2019 Highlights

Watch a 2-minute highlights video of the 2019 event.

2019 Presentations

Jim Mellon

 

Dr Aubrey de Grey

Rejuvenation Biotechnology: on track to be the biggest industry ever

Nir Barzilai

Unlocking the secrets of longevity

Declan Doogan

Health in the Age of Longevity

Reason

Gene Therapies to Reverse Immunosenescence and Atherosclerosis

Liz Parrish

Treating Ageing with Gene Therapy

William Baines

Five Alarm Bio

Petr Fedichev

Gero

Joe Hawkins

SleepCogni

Yuri Deigin

Youthereum

Sergey Young

7 Signs of Longevity Revolution

Dani Saurymper

Younger for Longer

Sponsors

Longevity Technology
Repair Biotechnologies
Juvenescence 2021
Afar